Kolexia
Cottin Vincent Pneumologie
Cottin Vincent
Pneumologie
Hôpital Louis Pradel
Bron, France
1.1 K Activités
2 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibrose pulmonaire Fibrose Fibrose pulmonaire idiopathique Maladies pulmonaires Pneumopathies interstitielles Hypertension artérielle Hypertension pulmonaire Sclérose Pneumopathie infectieuse

Collaborateurs

Voir plus
Crestani Bruno
Crestani Bruno
Hôpital Bichat-Claude-Bernard, Paris, France
Nunes Hilario
Nunes Hilario
Hôpital Avicenne, Bobigny, France
Traclet Julie
Traclet Julie
Hôpital Louis Pradel, Bron, France
Cordier Jean Francois
Cordier Jean Francois
Hôpital Louis Pradel, Bron, France

Industries

Voir plus
Boehringer Ingelheim
113 collaboration(s)
Dernière en 2023
Roche
37 collaboration(s)
Dernière en 2023
RE-IMAGINE Health Agency
29 collaboration(s)
Dernière en 2021
AstraZeneca
16 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
I-FILE: An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology: I-FILE
Essai Clinique (Erasmus Medical Center)   19 mars 2024
ILDnose: Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic Interstitial Lung Disease
Essai Clinique (Erasmus Medical Center)   18 mars 2024
TETON-2: A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)
Essai Clinique (United Therapeutics)   14 mars 2024
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
Essai Clinique (Aerovate Therapeutics)   11 mars 2024
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Essai Clinique (United Therapeutics)   11 mars 2024
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs): A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
Essai Clinique (Boehringer Ingelheim)   06 mars 2024
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF): A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Essai Clinique (Boehringer Ingelheim)   06 mars 2024
RE-LAM-CE: National Lymphangioleiomyomatosis Registry, France
Essai Clinique (Vincent COTTIN)   21 février 2024
Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial.
American journal of respiratory and critical care medicine   14 février 2024
Similarities and differences of interstitial lung disease associated with pathogenic variants in SFTPC and ABCA3 in adults.
Respirology (Carlton, Vic.)   12 février 2024